265 related articles for article (PubMed ID: 26606973)
1. Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project.
Ling Z; Liu X; Cheng Y; Jiang X; Jiang H; Wang Y; Li L
Sci Rep; 2015 Nov; 5():17098. PubMed ID: 26606973
[TBL] [Abstract][Full Text] [Related]
2. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Virus Infection Alters Gut Microbiota Composition in Mice.
Zhu Q; Xia P; Zhou X; Li X; Guo W; Zhu B; Zheng X; Wang B; Yang D; Wang J
Front Cell Infect Microbiol; 2019; 9():377. PubMed ID: 31750262
[TBL] [Abstract][Full Text] [Related]
5. Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease.
Xu M; Wang B; Fu Y; Chen Y; Yang F; Lu H; Chen Y; Xu J; Li L
Microb Ecol; 2012 Feb; 63(2):304-13. PubMed ID: 21814872
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
7. The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection.
Yang R; Xu Y; Dai Z; Lin X; Wang H
J Immunol Res; 2018; 2018():2361963. PubMed ID: 30148173
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure.
Wang K; Zhang Z; Mo ZS; Yang XH; Lin BL; Peng L; Xu Y; Lei CY; Zhuang XD; Lu L; Yang RF; Chen T; Gao ZL
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34006193
[TBL] [Abstract][Full Text] [Related]
9. Altered oral microbiota in chronic hepatitis B patients with different tongue coatings.
Zhao Y; Mao YF; Tang YS; Ni MZ; Liu QH; Wang Y; Feng Q; Peng JH; Hu YY
World J Gastroenterol; 2018 Aug; 24(30):3448-3461. PubMed ID: 30122883
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis.
Shu W; Shanjian C; Jinpiao L; Qishui O
Ann Hepatol; 2022; 27(2):100676. PubMed ID: 35093600
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
Chakravarti A; Verma V; Jain M; Kar P
Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy.
Kang Y; Cai Y
J Hosp Infect; 2017 Aug; 96(4):342-348. PubMed ID: 28545829
[TBL] [Abstract][Full Text] [Related]
13. Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.
Lu H; Wu Z; Xu W; Yang J; Chen Y; Li L
Microb Ecol; 2011 Apr; 61(3):693-703. PubMed ID: 21286703
[TBL] [Abstract][Full Text] [Related]
14. Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease.
Lin MJ; Su TH; Chen CC; Wu WK; Hsu SJ; Tseng TC; Liao SH; Hong CM; Yang HC; Liu CJ; Wu MS; Kao JH
Gut Pathog; 2023 May; 15(1):24. PubMed ID: 37218009
[TBL] [Abstract][Full Text] [Related]
15. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis.
Yu X; Guo R; Ming D; Su M; Lin C; Deng Y; Lin Z; Su Z
J Gastroenterol Hepatol; 2014 May; 29(5):1065-72. PubMed ID: 24236690
[TBL] [Abstract][Full Text] [Related]
16.
Chen T; Ding R; Chen X; Lu Y; Shi J; Lü Y; Tang B; Zhang W; Ye C; Yuan M; Yang Z
Bioengineered; 2021 Dec; 12(1):8233-8246. PubMed ID: 34592890
[TBL] [Abstract][Full Text] [Related]
17. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
19. Endemic hepatitis B virus infection and chronic liver disease mortality in the Republic of Palau, 1990-2002.
Vogt TM; Goldstein ST; Kuartei S
Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1130-4. PubMed ID: 16765396
[TBL] [Abstract][Full Text] [Related]
20. Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection.
Chen Y; Chen Z; Guo R; Chen N; Lu H; Huang S; Wang J; Li L
Diagn Microbiol Infect Dis; 2011 Aug; 70(4):492-8. PubMed ID: 20846815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]